← Leaderboards
Stephen Philip Schoenberger
La Jolla Inst For Allergy &Immunolgy
$11,521,738
Attributed
$16,792,935
Total exposure
9
Grants
7
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.5M · FY2005–25$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$16,792,935 · 9
By mechanism
R01$9,121,736 · 4
U01$7,216,726 · 2
R21$423,473 · 1
R13$31,000 · 2
Top collaborators
- J. Silvio Gutkind6 shared
- Anjana Rao6 shared
- John M Maris4 shared
- Rebekah White3 shared
Others in their field
Top investigators on “Response”
- Lawrence Corey · Fred Hutchinson Cancer Center$677,505,141
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$532,027,174
- Barton F Haynes · Duke University$497,761,007
- Jeffrey P Krischer · University Of South Florida$397,532,270
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$342,310,423
Research focus
ResponseTumorAntigensT-LymphocyteIn VivoBaseMediatingImmuneCd8b1 GeneImmune ResponseT Cell ResponsePhenotypeInflammatoryMalignant NeoplasmsAutoimmunityCellsMolecularSignal TransductionLeadNovel StrategiesMouse ModelPathway InteractionsImmune SystemProduction
Grant awards (39)
Personalized neuroblastoma vaccines$809,608
U01 · FY2025 · CA
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer$594,402
R01 · FY2025 · CA
Personalized neuroblastoma vaccines$777,310
U01 · FY2024 · CA
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer$564,526
R01 · FY2024 · CA
Personalized neoantigen vaccines using nucleoside-modified mRNA-lipid nanoparticles$178,000
U01 · FY2024 · CA
Personalized neuroblastoma vaccines$839,128
U01 · FY2023 · CA
Irreversible Electroporation (IRE) Combined with CD40 Agonism as In Situ Vaccine Therapy for Pancreatic Cancer$629,181
R01 · FY2023 · CA
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$838,091
U01 · FY2022 · DE · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$849,319
U01 · FY2021 · DE · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$827,143
U01 · FY2020 · DE · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$366,000
U01 · FY2020 · DE · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$852,739
U01 · FY2019 · DE · contact PI
Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers$879,388
U01 · FY2018 · DE · contact PI
Cellular and Molecular Regulation of CD8+ T cell memory$442,500
R01 · FY2017 · AI · contact PI
Cellular and Molecular Regulation of CD8+ T cell memory$442,500
R01 · FY2016 · AI · contact PI
Local control of anti-tumor/anti-self reactivity in low-affinity ACT$192,488
R21 · FY2016 · CA · contact PI
Cellular and Molecular Regulation of CD8+ T cell memory$442,500
R01 · FY2015 · AI · contact PI
Local control of anti-tumor/anti-self reactivity in low-affinity ACT$230,985
R21 · FY2015 · CA · contact PI
Cellular and Molecular Regulation of CD8+ T cell memory$442,500
R01 · FY2014 · AI · contact PI
Cellular and Molecular Regulation of CD8+ T cell memory$415,950
R01 · FY2013 · AI · contact PI
La Jolla Immunology Conference$7,000
R13 · FY2013 · AI · contact PI
La Jolla Immunology Conference$8,500
R13 · FY2012 · AI · contact PI
Programming of CD8+ T Cell Tolerance by B Cell APC$449,155
R01 · FY2011 · AI · contact PI
La Jolla Immunology Conference$8,500
R13 · FY2011 · AI · contact PI
Programming of CD8+ T Cell Tolerance by B Cell APC$453,692
R01 · FY2010 · AI · contact PI
Programming of CD8+ T Cell Tolerance by B Cell APC$613,334
R01 · FY2009 · AI · contact PI
TRAIL-mediated regulation of T help for CTL$283,445
R01 · FY2009 · CA · contact PI
2009 Antigen Cross Presentation Gordon-sponsored Meeting$7,000
R13 · FY2009 · AI · contact PI
Programming of CD8+ T Cell Tolerance by B Cell APC$460,020
R01 · FY2008 · AI · contact PI
TRAIL-mediated regulation of T help for CTL$283,445
R01 · FY2008 · CA · contact PI
Programming of CD8+ T Cell Tolerance by B Cell APC$487,620
R01 · FY2007 · AI · contact PI
TRAIL-mediated regulation of T help for CTL$283,445
R01 · FY2007 · CA · contact PI
TRAIL-mediated regulation of T help for CTL$291,911
R01 · FY2006 · CA · contact PI
TRAIL-mediated regulation of T help for CTL$284,760
R01 · FY2005 · CA
MANIPULATION OF CD40 CD40L IN CTL BASED IMMUNOTHERAPY$253,800
R01 · FY2004 · CA
MANIPULATION OF CD40 CD40L IN CTL BASED IMMUNOTHERAPY$253,800
R01 · FY2003 · CA
MANIPULATION OF CD40 CD40L IN CTL BASED IMMUNOTHERAPY$253,800
R01 · FY2002 · CA
MANIPULATION OF CD40 CD40L IN CTL BASED IMMUNOTHERAPY$253,800
R01 · FY2001 · CA
MANIPULATION OF CD40 CD40L IN CTL BASED IMMUNOTHERAPY$241,650
R01 · FY2000 · CA